Oncobiologics, Inc. (OTLK) Reports Q4 Loss, Lags Revenue Estimates

Oncobiologics, Inc. (OTLK) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.35%. A quarter ago, it was expected that this company would post a loss of $0.42 per share when it actually produced a loss of $0.44, delivering a surprise of -4.76%.Over the last four quarters, the company has su ...